Literature DB >> 16760728

Case series: clinical management of persistent mechanical assist device driveline drainage using vacuum-assisted closure therapy.

Sam Baradarian1, Marcia Stahovich, Susan Krause, Robert Adamson, Walter Dembitsky.   

Abstract

Percutaneous driveline lead and pocket sites are potential sources of drainage that can lead to infection. Some patients experience a slower closure of tissue growth into the driveline. The management of chronically open and or draining driveline wounds is a challenge. The KCI vacuum-assisted closure (VAC) device is a noninvasive negative-pressure therapy that promotes the healing of wounds not responding to conventional treatment. Vacuum-assisted closure therapy has proven safe, effective, and cost efficient by decreasing the number of dressing changes and length of stay. The left ventricular assist device (LVAD) team initiated VAC therapy in 3 patients. The tunneling method allowed the wound to heal from the inside out. The dressing was changed every 3 days, and the size and depth of the wound was monitored. Patients may be sent home using a portable VAC device until wound closure is obtained, which decreases the hospital length of stay. Our experience with three patients suggests the VAC device can be used for draining and tunneling LVAD driveline-site wounds and may prevent fistula formation. It is especially useful for patients with ascites that may be draining along the driveline tract. The sites showed increased granulation, decreased drainage, and a reduced bacterial burden after having the device in place.

Entities:  

Mesh:

Year:  2006        PMID: 16760728     DOI: 10.1097/01.mat.0000204760.48157.cc

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  9 in total

Review 1.  Ventricular assist devices: pharmacological aspects of a mechanical therapy.

Authors:  O Wever-Pinzon; J Stehlik; A G Kfoury; J V Terrovitis; N A Diakos; C Charitos; D Y Li; S G Drakos
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

2.  Cardiac assist device infections.

Authors:  Shmuel Shoham; Leslie W Miller
Journal:  Curr Infect Dis Rep       Date:  2009-07       Impact factor: 3.725

Review 3.  Technique for minimizing and treating driveline infections.

Authors:  Leora T Yarboro; James D Bergin; Jamie L W Kennedy; Carole C Ballew; Emily M Benton; Gorav Ailawadi; John A Kern
Journal:  Ann Cardiothorac Surg       Date:  2014-11

4.  Development and long-term in vivo testing of a novel skin-button system for preventing driveline infection of an implantable VAD system.

Authors:  Toshihide Mizuno; Yashushi Nemoto; Tomonori Tsukiya; Yoshiaki Takewa; Yoshiyuki Taenaka; Eisuke Tatsumi
Journal:  J Artif Organs       Date:  2011-07-09       Impact factor: 1.731

Review 5.  Impact of adverse events on ventricular assist device outcomes.

Authors:  Aleksandar Adzic; Snehal R Patel; Simon Maybaum
Journal:  Curr Heart Fail Rep       Date:  2013-03

6.  Infectious Complications of Mechanical Circulatory Support (MCS) Devices.

Authors:  Stanley I Martin
Journal:  Curr Infect Dis Rep       Date:  2013-09-29       Impact factor: 3.725

Review 7.  Clinical management for complications related to implantable LVAD use.

Authors:  Koichi Toda; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-11-05

Review 8.  Left ventricular assist device-related infections: past, present and future.

Authors:  Sanjay Maniar; Sreekanth Kondareddy; Veli K Topkara
Journal:  Expert Rev Med Devices       Date:  2011-09       Impact factor: 3.166

Review 9.  The Importance of the Management of Infectious Complications for Patients with Left Ventricular Assist Device.

Authors:  Michinari Hieda; Makoto Sata; Takeshi Nakatani
Journal:  Healthcare (Basel)       Date:  2015-08-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.